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Pentatricopeptide repeat proteins (PPR) proteins are helical-repeat proteins that bind 
RNA in a modular one-nucleotide:one-repeat fashion. The specificity of a given PPR repeat 
is dictated by amino acids at two-positions, which recognize a particular nucleotide through 
hydrogen bonds with the Watson-Crick face. The combinations of amino acids at these 
positions that give rise to nucleotide specificity is referred to as the PPR-code. The modular 
and programmable nature of PPR proteins makes them promising candidates for use in 
applications that require targeting a protein to a specific RNA sequence. One mechanism by 
which PPR proteins act involves the remodeling of inhibitory RNA hairpins that sequester a 
ribosome binding site upstream of the gene. However, other evidence suggests that PPR 
protein-RNA interactions can be inhibited by RNA secondary structure. It is not clear what 
parameters determine which partner prevails in binding to the RNA. I investigated how the 
position and strength of an RNA structure impacts PPR:RNA binding and determined that 
even weak RNA structures are able to inhibit PPR:RNA binding. Additionally, I investigated 
the driving forces of PPR:RNA binding kinetics. Together, these parameters will benefit the 
design of synthetic PPR proteins for specific purposes.  
Several groups have demonstrated that synthetic PPR proteins can be designed to bind a 
specified RNA sequence in vitro.  However, no work has been performed using engineered, 
 v 
or designer PPR proteins in an in vivo setting. I demonstrated the feasibility of using a 
designer PPR protein to bind a specified RNA in vivo, and I applied this capability for a 
specific application – the purification of an endogenous ribonucleoprotein particle to 
identify associated proteins.  
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Ribonucleic acid (RNA) binding proteins mediate many aspects of RNA metabolism and 
gene expression. These RNA metabolic events include the synthesis, structural 
rearrangement, post-transcriptional modification, and the processing and degradation of 
RNAs. From the time of its inception to its degradation, an RNA molecule is covered in a 
plethora of RNA binding proteins that mediate these events. The proper maintenance of 
these events drives the life cycle of RNA within a cell and is dependent on the correct 
functionality of RNA binding proteins. The specificity and affinity of an RNA binding 
protein is vital to its functionality and the understanding of these binding parameters is 
leading to the engineering of RNA binding proteins for the development of biotechnological 
tools surrounding many aspects of gene expression [Lunde et al. 2007, Hall 2016, Chen 
2016, Yagi et al. 2013].  
Pentatricopeptide repeat (PPR) proteins are alpha helical repeat proteins that recognize 
specific sequences of RNA. PPR proteins are found in all eukaryotes, but the family has 
expanded to over 400 members in land plants. PPR proteins are responsible for a multitude 
of RNA metabolic events in organelles. Each PPR protein is made up of between two and 
30 PPR repeats, or motifs, and each PPR motif is made up of about 35 amino acids with has 
conserved sequence and structural features that define it as a PPR motif, but with 
considerable variability beyond these conserved features [Barkan and Small 2014, Small et al. 
2000]. Each repeat recognizes a single RNA nucleotide in a modular one-repeat one-
nucleotide fashion. Similar to TALE-repeat and PUF-repeat nucleotide interactions, the 
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specificity of each PPR repeat is dictated by the identity of amino acids at two positions 
[Boch et al. 2009, Wang et al. 2002, Barkan et al. 2012]. This modular and predictable 
binding interface is ideal for engineering customized RNA binding proteins for in vivo 
applications. This dissertation investigates mechanistic details of PPR:RNA binding as well 
as the applications of engineered PPR proteins for in vivo synthetic RNA biology purposes. 
 
Nuclear encoded RNA binding proteins have co-evolved with RNA metabolism in 
chloroplasts 
 Nuclear encoded proteins, such as PPR proteins, regulate many steps of gene expression 
and RNA metabolism inside the chloroplast. The chloroplast itself is a product of 
endosymbiosis and co-evolution between an ancient cyanobacteria and a eukaryotic ancestor 
cell. Throughout the co-evolution process the chloroplast has transferred many of its 
original cyanobacterial genes to the nucleus, yet it still retains about 100 of its own genes 
which include transcriptional and translational components and subunits of the 
photosynthetic apparatus [Reviewed in Timmis et al. 2004]. Similar to the bacterial ancestor, 
the chloroplast genome is arranged in polycistronic transcript units. However, the 
chloroplast has gained many post-transcriptional RNA processing steps that are not found in 
the bacterial ancestor including cleavage, group II intron splicing, editing, and the processing 
of full-length transcripts down to shorter isoforms [Barkan 2011]. These events are 
facilitated by nuclear encoded proteins that harbor RNA binding motifs that are not found 
in the bacterial ancestors of the DNA comprising organelles, and therefor evolved post-
endosymbiosis [Barkan and Small 2014]. The PPR family is a prominent example, and 
members of the PPR family influence virtually every RNA mediated step in mitochondrial 
and chloroplast gene expression.  
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PPR proteins are helical-repeat proteins that recognize specific sequences of RNA 
 The most widely-recognized RNA binding domains, such as RRM and zinc finger 
domains, are globular and their RNA recognition modes are idiosyncratic and unpredictable 
[Lunde et al. 2007]. PPR proteins, on the other hand, are made up of many modular motifs 
whose nucleotide specificity is, to some extent, predictable and customizable. PPR proteins 
are made up of many tandem helical motifs that stack to form a super-helix, or alpha 
solenoid [Small et al. 2000, Shen at al. 2016]. Each motif recognizes a single RNA nucleotide 
and nucleotide specificity is determined by the identity of amino acids at two specific 
positions. PPR proteins bind to RNA in a “parallel” fashion, that is, the amino-terminus of 
the protein recognizes the 5’ nucleotides in a binding site and the carboxy-terminus of the 
protein binds to 3’ nucleotides.  
 The PPR protein family can be divided into two sub families: P-type, and PLS-type. P-
type PPR proteins are comprised entirely of tandem P-type motifs which are all about 35 
amino acids in length (Fig 1A). P-type PPR proteins are involved in post-transcriptional 
RNA isoform processing, as well as cleavage, splicing, and translational activation and 
repression. Some P-type PPR proteins have additional carboxy-terminal domains such as the 
MutS-related (SMR) domain, however, the specific function of this domain is unknown 
[Barkan and Small 2014]. PLS-type PPR proteins are made up of P-type motifs, as well as 
long (L) and short (S) motifs, which are about 36 amino acids and 31 amino acids 
respectively (Fig 1B). These motifs are arranged in tandem arrays of PLS triplets (Fig 1A). 
These proteins almost always contain an additional DYW or E domain which is proposed to 
be involved in the catalysis of cytidine deamination, (C to U editing) in messenger RNA 
(mRNA), and also is responsible for recruiting other proteins of the editing complex. There 
is some evidence that PLS type PPR proteins are involved in cleavage, splicing, and the 
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processing of transcript isoforms. Both P- and S- type motifs recognize specific RNA 
nucleotides through the combinatorial action of amino acids at the sixth position in each 
repeat, and the first position in the following repeat (denoted 6 and 1’ in some citations) 
[Reviewed in Barkan and Small 2014]. In both PLS-type and P-type PPR proteins the PPR 
motifs define the RNA binding site. The C to U editing function of PLS-type PPR proteins 
is proposed to be carried out by the carboxy-terminus domain. On the other hand, the 
diverse functions of P-type PPR proteins are carried out by simply sequestering long 
segments of RNA – which prevents the RNA from interacting with other proteins or RNA, 
or exposes a cis-element masked in an RNA hairpin that is then free to interact with other 
proteins or RNA [Prikryl et al. 2011] [reviewed in Barkan and Small 2014]. 
 
Most functions of P-type PPR proteins can be explained by their ability to sequester 
long stretches of RNA nucleotides 
 The RNA-metabolic events attributed to P-type PPR proteins can largely be explained 
by their simple capacity to sequester long stretches of RNA nucleotides. This theme was 
originally elucidated in studies of a maize protein called PPR10, a protein with 19 PPR 
repeats. It was observed in ppr10 mutant plants that processed isoforms of chloroplast atpH 
and psaJ transcripts failed to accumulate but their precursors accumulated normally. This 
Figure 1. PPR protein subfamilies. 
Figure adapted from Cheng et al. 
2016. (A) PPR proteins can be 
divided into P-type or PLS-type 
proteins. PLS-type proteins almost 
always contain an editing domain. (B) 
Consensus motifs of P, L, and S PPR 
motifs. Capitol letters represent 
highly conserved amino acids.  
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suggested that PPR10 is required to stabilize the processed transcripts that don’t accumulate 
in its absence. It was determined that PPR10 binds intercistronic regions between the atpI 
and atpH genes and the psaJ and rpl33 genes and acts as a blockade to exonucleases in the 5’ 
and 3’ directions, protecting the atpH and psaJ genes from exonuclease degradation. By this 
mechanism PPR10 stabilizes and defines the ends of these processed isoforms. Both of 
these PPR10 binding sites are similar in sequence and evolutionarily conserved suggesting a 
sequence specific recognition mechanism by PPR10. Subsequently, it became clear that most 
RNA termini in chloroplasts are stabilized by PPR proteins, with different members of the 
family binding different untranslated regions of mRNAs to mediate this effect [Zhelyazkova 
et al. 2012]. 
Additionally, PPR10 and several other PPR proteins have been shown to activate the 
translation of genes downstream of their binding sites. In vitro data with PPR10 elucidated 
this mechanism. RNA structure prediction programs predicted PPR10’s atpH binding site to 
pair with, and sequester, a ribosome binding site just upstream of the atpH start codon. In 
vitro RNAse structure probing experiments showed that PPR10 was able to prevent the 
formation of the RNA hairpin and expose the ribosome binding site [Pfalz et al. 2009, 
Prikryl et al. 2011]. Preventing the formation of an RNA hairpin is expected given that PPR 
proteins bind to the Watson-Crick face of a nucleotide. By sequestering these nucleotides, 
PPR10 prevents them from basepairing with the ribosome binding site (RBS), exposing the 
RBS. This suggested an indirect role for PPR10 in translational activation of atpH by 
influencing RNA structure and exposing a masked ribosome binding site.  
These findings suggested that many of the RNA metabolic events attributed to PPR 
proteins could be explained by their ability to sequester long stretches of nucleotides with 
high affinity. PPR proteins can sequester nucleotides and prevent other proteins, such as 
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exonucleases, from interacting with that stretch of nucleotides – leading to the stability of 
processed transcript isoforms (Fig 2A). This sequestration of nucleotides can also prevent 
the masking of cis-elements by inhibitory RNA hairpins, and by doing so the PPR protein 
could unmasks cis-elements involved in translational activation, cleavage, and group II 





The “PPR code”: PPR motifs recognize specific RNA nucleotides through the 
identity of amino acids at two positions 
 Before it was recognized that PPR proteins bind RNA, there was only one example of an 
RNA binding motif consisting of helical repeats – the PUF motif. PUF proteins are helical 
repeat proteins, independently evolved from PPR proteins, whose repeating motifs 
recognize RNA through a three-amino-acid code, which was discovered in 2002 [Wang et al. 
2002]. The sequence specificity of PPR proteins and their repetitive motifs suggested a 
modular, programmable nucleotide recognition mode similar to PUF-RNA interactions. 
Through a combination of biochemical and computational approaches that took advantage 
of the well-defined binding sites of PPR10 and several other PPR proteins, it was 
determined that the sixth amino acid in each repeat and the first amino acid in the following, 
carboxy-terminal repeat conferred nucleotide specificity (Fig 2B and C) [Barkan et al. 2012]. 
Figure 2. Mechanisms of PPR proteins. Figure adapted from Barkan and Small 
2014. (A) PPR proteins act as site specific barriers blocking other proteins, such as 
nucleases, from interacting with the RNA. (B) PPR proteins can influence RNA 
structure, preventing the formation of RNA hairpins and exposing masked cis-
elements like splicing sites, or ribosome binding sites 
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This “PPR code” was confirmed through a series of biochemical experiments that 
reprogramed PPR10 according to the code to bind novel RNA sequences. Subsequently, the 
structural basis of the code was elucidated through X-ray crystallography of complexes 
between synthetic PPR proteins (built from consensus PPR motifs) and their RNA ligands 





Although PPR proteins, to some degree, exhibit a programmable mode of nucleotide 
recognition, the PPR-code is unable to predict with certainty where native PPR proteins bind 
in vivo. A comprehensive analysis of PPR10’s sequence specificity in vitro showed that only a 
subset of the nucleotides bound with specificity by PPR10 could be explained by the PPR 
code. Those experiments also showed that the specificity and affinity of the PPR10:atpH 
interaction is not evenly distributed among each individual repeat [Miranda et al. 2017]. This 
Figure 3. PPR proteins recognize specific nucleotides through the “PPR-code”. 
(A) Crystal structure of PPR10 representing super helical structure (pdb:4M57) [Yin et al 
2013]. (B) PPR motifs each recognize a single nucleotide. (C) Physical basis for 
nucleotide specificity of PPR motifs by the 6 and 1’ amino acids. Blue circles represent 
water molecules (pdb: 5I9D, 5I9F, 5I9G, 5I9H) [Shen et al. 2016]. 
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and other data show that native PPR proteins have idiosyncratic features that complicate the 
prediction of their binding sites and their redesign for new purposes.   
 
Designer PPR proteins: engineered RNA binding proteins for synthetic biology 
To overcome the idiosyncratic features found within native PPR proteins, several groups 
independently developed consensus PPR motifs to attempt to create more predictable RNA 
binding proteins based on the PPR architecture (Fig 4) [Shen et al. 2015, Gully et al. 2015, 
Coquille et al. 2014]. These consensus motifs were created by aligning native P-type PPR 
motifs found in plants and forming a consensus sequence from the most common amino 
acids found at each position (aside from the specificity-determining positions). Synthetic, or 
designer PPR proteins were created using these consensus PPR motifs in combination with 
the amino acid combinations found in the PPR-code. 
 
The first synthetic PPR proteins were rather simple: only 5-11 repeats long and designed 
to bind to mononucleotide sequences. Their analysis showed that designer PPR proteins 
with at least six repeats could bind to their intended target sequences. These proteins showed 
specificity for their target sequences over other mononucleotide sequences; however the 
analysis of their sequence specificity was quite superficial [Shen et al. 2015, Gully et al. 2015, 
Coquille et al. 2014]. In my work, I helped to take this to a more sophisticated level by 
designing several synthetic PPR proteins (11 and 14 repeats) using previously published 
Figure 4. Consensus PPR 
motifs. Consensus PPR 
motifs adapted from 
Coquille et al. 2014, Gully et 
al. 2015, and Shen et al. 2015.  
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consensus motifs and consensus motifs of my own design. The sequence-specicity of these 
proteins was then assayed by my collaborator, using an in vitro “bind-n-seq” assay [Miranda et 
al. 2018]. This work showed that the RNA binding specificity landscape of designer PPR 
proteins could be explained by the PPR-code; that is, PPR tracts made up of consensus 
motifs do not exhibit the idioscyncratic features that are characteristic of native PPR 
proteins. The work also suggested that affinity and specificity of designer PPR proteins was 
greatest when designer PPR proteins are shorter than 12 repeats.  
Engineered PPR proteins offer the ability to target specific sequences of RNA through 
their PPR tracts and to carry out specific functions on RNA through the action of an 
accessory domain. A in vivo PPR protein-based application would not require modification of 
the RNA sequence itself, and they could be easily targeted to organelles where guide RNAs 
and oligonucleotides have yet to be successfully targeted. Additionally, the different types of 
PPR motifs (P, L, and S) offer a flexible template from which the binding kinetics of an 
engineered PPR protein could be customized to the application. All together these factors 
offer a promising future for the use of engineered PPR proteins in vivo.  
 
Knowledge gap: What is the relationship between RNA structure stability and 
PPR:RNA binding; and can designer PPR proteins be used for synthetic biology 
purposes in vivo? 
 As described above, PPR proteins, such as PPR10, have the ability to influence local 
RNA structure around their binding sites. However, other evidence suggests that RNA 
secondary structure inhibits PPR:RNA binding [Miranda et al. 2017, Kindgren et al. 2015, 
Zoschke et al 2016], which is to be expected given that PPR motifs make sequence-specific 
contacts with the Watson-crick face of the aligned nucleotide [Shen et al. 2016]. It is unclear 
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what parameters determine which binding partner the RNA will bind to. In the following 
chapter I address this question by describing how the stability and position of RNA structure 
sequestering a PPR binding site influences PPR:RNA binding, a result that has implications 
for the design of synthetic PPR for in vivo use. Additionally, I describe other characteristics 
of PPR:RNA binding affinity and kinetics in this chapter that aid in our understanding of the 
mechanisms of PPR:RNA binding and how they compare to globular RNA binding 
proteins.   
 My collaboration with Rafael Miranda showed that designer PPR proteins bind to their 
intended targets with a high degree of specificity in vitro.  However, there are no reports of 
exploiting this potential for in vivo applications.  In Chapter III I develop the use of designer 
PPR proteins as an in vivo technology and describe how they can be used in vivo as an 
“affinity tag” to purify a specified transcript for the purpose of discovering the population of 
proteins bound to that RNA. Chapter IV is a summary of my work and its future 
implications in the development of designer PPR proteins as a tool for synthetic RNA 
biology.  
 Chapter II of this dissertation contains unpublished co-authored material. I was first 
author of this work and Alice Barkan was the principle investigator. Bryce Civic was a co-
author of this material. Chapter II has been submitted for publication in PLOSONE. 
Chapter III of this dissertation contains unpublished co-authored material. I was first author 
of this work and Alice Barkan was the principle investigator. Rosalind Williams-Carrier and 
Kenneth Watkins co-authored this material. Chapter III has been submitted for publication 
in Nature Biotechnology.  
 
BRIDGE TO CHAPTER II 
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 To fully develop the potential of designer PPR proteins for synthetic biology purposes, a 
better understanding of the details of PPR:RNA interactions are necessary – for example, 
the kinetics of PPR-RNA interactions and the competition between RNA folding and PPR 























EFFECTS OF RNA STRUCTURE AND SALT CONCENTATION ON THE 
AFFINITY AND KINETICS OF INTERACTIONS BETWEEN 
PENTATRICOPEPTIDE REPEAT PROTEINS AND  
THEIR RNA LIGANDS 
 
This chapter contains unpublished co-authored material. Bryce Civic performed some 
RNA thermal melts. J.J. McDermott performed all other experiments. A. Barkan and J.J. 
McDermott wrote the manuscript 
 
INTRODUCTION 
 Pentatricopeptide repeat (PPR) proteins comprise a large family of RNA binding 
proteins that function primarily in the context of mitochondrial and chloroplast gene 
expression [1, 2]. PPR proteins influence every RNA-mediated step in organellar gene 
expression, including RNA editing, group II intron splicing, RNA stability, and translation. 
Most PPR proteins act specifically on a handful of RNAs in vivo, and this functional 
specificity is reflected by sequence-specific RNA interactions in vitro. PPR proteins consist of 
tandem degenerate repeats of approximately 35-amino acids, each of which forms a helical 
hairpin. Consecutive repeats stack to form an elongated superhelix that binds single-stranded 
RNA. The sequence specificities of PPR proteins are, to some extent, predictable and 
customizable. Each repeat binds a single nucleotide, with nucleotide specificity dictated by 
the identities of two amino acids: the sixth amino acid in a given PPR motif and the first 
amino acid in the next (denoted as the 6 and 1’ amino acids according to the nomenclature 
in ref [3]).  These two amino acids form a hydrogen bond network with the Watson-Crick 
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face of the specified nucleotide [4, 5]. However, this “PPR code” is insufficient to fully 
explain the sequence specificities of natural PPR proteins, many of which have idiosyncratic 
features [see, e.g. 6].  
PPR proteins are found in all eukaryotes, but the family is particularly large in land 
plants, where it is made up of more than 400 members containing between two and 
approximately 30 PPR motifs. These can be divided into two subfamilies, termed P and PLS 
[7]. PLS proteins consist of variant repeat motifs and function primarily to specify sites of 
RNA editing [2].  P-type PPR proteins consist primarily of canonical “P-type” motifs, and 
are involved in group II intron splicing, transcript stabilization, and translational control. It is 
intriguing that proteins with this simple architecture can elicit such diverse effects on RNA. 
P-type PPR proteins have only rarely been observed to interact with other proteins [8]; 
instead, most functions of P-type PPR proteins may result from their capability to form an 
unusually long protein-RNA interface. For example, many PPR proteins with long repeat 
tracts stabilize RNA adjacent to their binding sites by blocking exoribonucleases [reviewed in 
2].  Furthermore, sequestration of a long RNA segment by a PPR protein can influence local 
RNA folding [9], which, in turn, may influence RNA stability, processing, or translation.  
PPR-RNA interactions are inhibited by RNA structures that involve nucleotides in the PPR 
binding site [6, 10, 11]. This inhibition is to be expected given that PPR motifs bind the 
Watson-Crick face of nucleobases.  However, there is evidence that PPR proteins can bind in 
vivo to RNAs even when a portion of the binding site is complementary to a nearby RNA 
sequence [9, 11]. In fact, this capability is proposed to underlie the ability of PPR proteins to 
stimulate translation and group II intron splicing [9]. To develop a better understanding of 
the parameters that influence the ability of a PPR protein to bind a site capable of pairing 
with a nearby RNA sequence, we analyzed the effects of RNA structures of varying 
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stabilities and position on the interaction between the maize protein PPR10 and its atpH 
RNA ligand. Our experiments include the use of Surface Plasmon Resonance (SPR) to 
examine the kinetics of PPR:RNA interactions, a parameter that is likely to impact the 
biological functions of PPR proteins and that has, to our knowledge, not been reported 
previously.   
 
RESULTS AND DISCUSSION 
Impact of RNA secondary structure on PPR10 binding affinity 
We selected PPR10 to explore the interplay between RNA folding and PPR binding 
because PPR10’s functions, structure, and sequence specificity have been well characterized 
[4, 6, 9, 12-15]. PPR10 consists of 19 tandem PPR motifs flanked by capping helices. PPR10 
localizes to chloroplasts, where it binds three sites that map in untranslated regions near the 
atpH, psaJ, and psaI genes. Of these, the site in the atpH 5’ UTR binds PPR10 with highest 
affinity, and these interactions have been most thoroughly characterized in vitro. PPR10’s 
minimal binding site at atpH spans 17-nucleotides, whereas its footprint (the region it 
protects from exoribonucleases) spans ~23 nucleotides (see Fig 1A). When PPR10 binds this 
site in vivo, it blocks exoribonucleases intruding from both the 5’- and 3’-directions and it also 
stimulates atpH translation. In vitro experiments provided evidence that PPR10 activates 
translation by sequestering RNA that would otherwise form an inhibitory structure with the 
atpH ribosome binding site [9].  
To assess the influence of RNA secondary structure on PPR10-RNA interactions, we 
designed a series of RNAs harboring the PPR10 atpH footprint flanked by stem-loops 
whose stems include nucleotides at either end of the PPR10 binding site (Fig 5A). 
Constructs were designed such that they had only one predicted structure. Loops were 
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composed solely of uridines to minimize interactions with other nucleotides in the RNA. We 
sought to distinguish how the number of binding-site nucleotides sequestered in the stem, 
the position of those nucleotides in the binding site, and the thermodynamic stability of the 
RNA structure impact PPR10 binding. Toward that end, we designed RNA hairpins of 
varying predicted thermodynamic stabilities that intrude on the PPR10 binding site to 
varying extents (Fig. 5A,B). To distinguish effects of hairpin stability from effects of hairpin 
position, we designed both “strong” and “weak” RNA structures to sequester the same 
nucleotides at each end of the binding site.  
We selected PPR10 to explore the interplay between RNA folding and PPR binding 
because PPR10’s functions, structure, and sequence specificity have been well characterized 
[4, 6, 9, 12-15]. PPR10 consists of 19 tandem PPR motifs flanked by capping helices. PPR10 
localizes to chloroplasts, where it binds three sites that map in untranslated regions near the 
atpH, psaJ, and psaI genes. Of these, the site in the atpH 5’ UTR binds PPR10 with highest 
affinity, and these interactions have been most thoroughly characterized in vitro. PPR10’s 
minimal binding site at atpH spans 17-nucleotides, whereas its footprint (the region it 
protects from exoribonucleases) spans ~23 nucleotides (see Fig 5A). When PPR10 binds this 
site in vivo, it blocks exoribonucleases intruding from both the 5’- and 3’-directions and it also 
stimulates atpH translation. In vitro experiments provided evidence that PPR10 activates 
translation by sequestering RNA that would otherwise form an inhibitory structure with the 















































+ 0.1 ± 0.1
- 3.6 ± 0.1
- 3.7 ± 0.1
+ 0.2 ± 0.1
- 5.6 ± 0.1#




























































37 °C & 
1M NaCl
3’ hairpins
























Figure 5. RNAs used to assess the effects of RNA secondary structure on PPR10 
binding. (A) Sequences and predicted secondary structures of the RNA ligands. 
PPR10 is shown aligned to its 23-nt in vivo footprint near atpH (atpH-23mer). PPR10’s 
minimal binding site is underlined [9]. The atpH-23mer is not predicted to form any 
structure. Nucleotides that are appended to the PPR10 footprint to introduce RNA 
structure are colored. (B) Predicted and measured stabilities of each RNA structure at 1 
M NaCl and 2.5 µM RNA. Predictions were made with mFold [16], which predicted 
only one structure for each RNA. The measured Tm and  G values were calculated 
based on thermal melting curves (n=3, +/- standard error of the mean). Values 
obtained at 180 mM NaCl, at different RNA concentrations, and from assays 
performed in reverse (transitions from high to low temperature) are shown in S1A Fig. 
*ND- Not determined due to lack of detectable structure. #The measured values for 
the 3’-5bp-strong RNA are based on a single inflection point at 66˚C, but the melting 
curve is biphasic (see panel C). Therefore, these values exaggerate the stability of this 
structure. (C) Representative melting curves at 1 M NaCl and 2. 5 µM RNA.  
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To assess the influence of RNA secondary structure on PPR10-RNA interactions, we 
designed a series of RNAs harboring the PPR10 atpH footprint flanked by stem-loops 
whose stems include nucleotides at either end of the PPR10 binding site (Fig 5A). 
Constructs were designed such that they had only one predicted structure. Loops were 
composed solely of uridines to minimize interactions with other nucleotides in the RNA. We 
sought to distinguish how the number of binding-site nucleotides sequestered in the stem, 
the position of those nucleotides in the binding site, and the thermodynamic stability of the 
RNA structure impact PPR10 binding. Toward that end, we designed RNA hairpins of 
varying predicted thermodynamic stabilities that intrude on the PPR10 binding site to 
varying extents (Fig. 5A,B). To distinguish effects of hairpin stability from effects of hairpin 
position, we designed both “strong” and “weak” RNA structures to sequester the same 
nucleotides at each end of the binding site.  
The maximum fraction of RNA bound was reduced in rough proportion to the stability 
of the RNA hairpin (Fig 6A), consistent with the anticipated competition between 
intramolecular RNA interactions and RNA-protein interactions. To determine whether 
PPR10 can capture additional RNA over time as the RNA transiently unfolds, we 
determined whether the maximum amount of the 5’-5bp-weak RNA bound to PPR10 
increased when the binding reaction was extended from 30 minutes to 2 hours (Fig 6B). The 
binding curves resulting from the two incubation times were very similar, indicating that the 
competing binding reactions (PPR10:RNA and intramolecular RNA:RNA) had reached 
equilibrium by 30 minutes.  
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Kinetics of PPR-RNA interactions 
The kinetics of the interactions between PPR proteins and their RNA ligands are likely 
to impact the outcome of competing protein-RNA and RNA-RNA interactions, and the 
effects of those interactions on gene expression. To our knowledge, kinetic parameters for 
PPR-RNA interactions have not been reported. We hypothesized that the long binding 
interface expected for many PPR-RNA complexes would lead to slower off-rates in 
comparison with proteins that contact fewer nucleotides. We used SPR to determine on- and 
off- rates for two PPR-RNA complexes: (i) PPR10 and its atpH binding site, and (ii) 
HCF152 and its binding site in the chloroplast psbH-petB intercistronic region (Fig 7). 
[PPR10] (nM)





























































Fig 6. Gel mobility shift assays 
demonstrating effects of RNA 
structure on PPR10 binding. The 
RNAs (5 pM) are diagrammed in 
Fig 1A. PPR10 was used at 
concentrations of 32 nM, 8 nM, 2 
nM six additional 2-fold dilutions. 
Data for replicate assays (n=2) are 
shown as separate points connected 
by a vertical line. (A) Summary of 
binding data for reactions incubated 
for 30 minutes. Representative gels 
are shown in S1B Fig. (B) 
Comparison of results for binding 
reactions incubated for 30 minutes 
and 2 hours. 
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HCF152 leaves a footprint of ~19-nucleotides and blocks 5’- and 3’-exoribonucleolytic 
degradation in vivo [17, 18], similar to PPR10’s effect near atpH.  
 
 






The on- and off-rates for the PPR10-atpH RNA predict an equilibrium constant (KD) of 
~ 10 pM (Fig 7A), similar to that inferred from equilibrium gel-mobility shift assays with the 
same protein preparation (S2E Fig). Both the on-rate and off-rate for the HCF152-petB 
RNA interaction were several-fold slower than the off-rate for the PPR10-atpH interaction 
(Fig 7B). Notably, the KD calculated from the measured kinetic parameters for HCF152-petB 
was roughly 30-fold lower than that we inferred from gel mobility shift assays [17]. Given 







































































3.9 x 106 ± 1 x 106
9.4 x 10-5 ± 3 x 10-5 *
40 ± 20
123

















2.4 x 107 ± 1 x 107








7.1 x 106 ± 2 x 167 **
4.3 x 10-4 ± 0.2 x 10-4 **




HCF152 + petB RNA PPR10 + 5’-6bp RNA
*
Fig 7. Analysis of PPR-RNA interactions by SPR. (A) SPR analysis of PPR10-atpH 
RNA interactions. Representative sensorgrams are shown at top. The data (black) were 
fit with a 1:1 Langmuir binding model (red). The RNAs are diagrammed in Fig 5A. 
PPR10 was used at a concentration of 5 nM and 2-fold dilutions thereof. Values in the 
table (+/- standard error of the mean) were calculated from data from three replicate 
experiments. A negative control demonstrating specificity of PPR10 for atpH RNA is 
shown in S2A Fig. Residuals are shown in S2C Fig. (B) SPR analysis of interactions 
between HCF152 and petB RNA. HCF152 was used at a concentration of 40 nM and 
2-fold dilutions thereof. Representative sensorgrams are shown. Values in the table 
(+/- standard error of the mean) were calculated from four replicate experiments. A 
negative control demonstrating the specificity of HCF152 for petB RNA is shown in 
S2A Fig. Residuals are shown in S2C Fig.  * Significantly different from data for the 
PPR10-atpH RNA interaction (P<0.05 according to a students t-test).    
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assays had not reached equilibrium and had therefore underestimated binding affinity. To 
address this possibility, we compared the results of gel mobility shift and filter binding assays 
incubated for either 30 minutes (as in the prior study) or overnight (Fig 8). The 30-minute 
incubation resulted in an apparent KD similar to that reported previously, whereas the 
overnight incubation resulted in an apparent KD similar to that inferred from kinetic data 
(Fig 7B). These results highlight the importance of ensuring that binding reactions have 
reached equilibrium when measuring KD’s for PPR-RNA interactions.   
 
The kinetic parameters for the PPR10-atpH interaction are similar to those reported for 
the U1A RRM domain and its RNA ligand [19, 20]. However, the on- and off- rates for the 
HCF152-petB interaction were slower than those for PPR10 and U1A with their cognate 
RNAs. Taken together, these data suggest that some PPR tracts form unusually long-lived 
complexes with their RNA ligand, but there is not a simple relationship between the length 
of the RNA-protein interface and the life-time or affinity of the complex.  
 







































































3.9 x 106 ± 1 x 106
9.4 x 10-5 ± 3 x 10-5 *
40 ± 20
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7.1 x 106 ± 2 x 167 **
4.3 x 10-4 ± 0.2 x 10-4 **




HCF152 + petB RNA PPR10 + 5’-6bp RNA
*
Figure 8. HCF152-petB RNA binding 
curves. HCF152-petB RNA binding curves 
generated from gel mobility shift (GMS) 
and filter binding (FB) assays, comparing 
results from 30 min or overnight (~13 h) 
binding reactions. Examples of the raw 
data are shown in S2D Fig. 
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We next addressed the effects of RNA structures sequestering a portion of the PPR10 
binding site on the kinetics of the PPR10-atpH RNA interaction. An RNA hairpin that 
includes two nucleotides of PPR10’s minimal binding site at the 5’-end (5’-6bp) decreased 
the on-rate and increased the off-rate several fold (Fig 9). Analogous results were obtained 
with an RNA harboring a similar structure at the 3’-end (3’-6bp, see S2B Fig); however, this 
RNA was tethered to the sensor chip at the opposite end from the other RNAs we 
examined by SPR, and this may impact the binding kinetics. In any case, reduced on-rates are 
anticipated to result from the competition with adjacent RNA for PPR10 access to its 
binding site. The accelerated off-rates suggest that the PPR-nucleotide interactions at each 
end of the PPR-RNA complex can breathe, allowing the intramolecular RNA duplex to 
intrude on the PPR10 binding site. It is unlikely that substantive interactions can be 
established without the participation of the two nucleotides at either end of the binding site 
based on the fact that deletion of one or two nucleotides at either end of the minimal 
binding site prevents any apparent PPR10 interaction in gel mobility shift assays [9]. 
Therefore, we favor an interpretation in which the RNA bound to PPR10 can exchange 
partners to form a competing intramolecular RNA interaction in a manner that is analogous 
to branch migration at the borders of alternative nucleic acid duplexes, and that once the 




Contribution of electrostatic interactions to establishing and maintaining the PPR-
RNA complex 
The ka for the PPR10-atpH RNA interaction (~2 x 107 M-1s-1, see Fig 3A) is considerably 
faster than that of diffusion-limited macromolecular interactions (~106 M −1 s−1) [21], 
suggesting that electrostatic interactions drive encounters between the protein and RNA. 
Indeed, the consensus PPR motif used in synthetic PPR designs includes a lysine residue that 
forms a salt-bridge to the phosphate backbone of bound RNA, and replacement of this 
lysine with alternative amino acids eliminates RNA binding [5, 22].  A basic “stripe” formed 
by lysines and arginines at this position is apparent also in the PPR10 crystal structure [4]; 
however, artifactual protein dimerization in the PPR10-RNA crystal structure [4, 13] 
prevents inferences from that structure about electrostatic contributions to PPR10:RNA 
binding.  To explore how electrostatic forces influence the kinetics of PPR-RNA 
interactions, we used SPR to monitor the effect of varying salt concentration on the on- and 
off-rate of PPR10-atpH RNA interactions (Fig 10). An increase in salt concentration 
increases the electrostatic shielding around charged molecules, thereby decreasing their 
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7.1 x 106 ± 2 x 167 **
4.3 x 10-4 ± 0.2 x 10-4 **




HCF152 + petB RNA PPR10 + 5’-6bp RNA
*
Figure 9. Effects of RNA structure on the 
kinetics of PPR10-RNA interactions. Effects 
of RNA structure on PPR10-RNA binding 
kinetics. The data are displayed as in panel (A). 
Values that are significantly different from those 
for the atpH-23mer are indicated (** = P<0.01, 
*** = P<0.001, according to a ratio paired t-
test). Residuals are shown in S2C Fig. The RNAs 
are diagrammed in Fig 5A. PPR10 was used at a 
concentration of 5 nM and 2-fold dilutions 
thereof. Values in the table (+/- standard error 
of the mean) were calculated from data from 
three replicate experiments. 
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mM to 300 mM caused a dramatic increase in the KD of the PPR10-RNA interaction. This 
was largely due to an effect on the on-rate, which decreased approximately 100-fold. By 







These results suggest that electrostatic forces make a large contribution to establishing 
interactions between PPR tracts and RNA, but make only a modest contribution to 
maintaining specific PPR-RNA interactions once established.  These trends are similar to 
those obtained for several proteins with RRM domains [19, 20]. It is intriguing in this 
context that the “stripe” of positive surface potential adjacent to the RNA binding groove in 
consensus PPR tracts is flanked by a stripe of negative surface potential [5, 22]. Thus, the 










































6.3 x 107 ± 1 x 107 *
2.4 x 107 ± 1 x 107
6.9 x 105 ± 2 x 105 *
1.1 x 10-4 ± 0.2 x 10-4 *
2.0 x 10-4 ± 0.2 x 10-4
4.1 x 10-4 ± 0.2 x 10-4 ***
1.8 ± 0.2 *
10 ± 3
830 ± 400 *
ka (M-1 s-1) kd (s
-1)
Figure 4.
Fig 10. Effect of salt concentration on the kinetics of PPR10-atpH RNA 
interactions. Representative sensorgrams are shown at top. PPR10 was used at 5 
nM and two-fold dilutions thereof.  The data (black) were fit with a 1:1 Langmuir 
binding model (red). Residuals are shown in S2C Fig. The table below shows the 
binding parameters inferred from the data (average of three replicate experiments 
+/- standard error). Values that show a significant difference from those at 150 




both attractive and repulsive forces that cooperate to optimize the alignment between the 
specificity determining amino acids and their cognate nucleobases.  
 
SUMMARY 
Results presented here suggest that non-specific electrostatic interactions drive PPR 
proteins towards RNA, and that stable binding to specific sequences is established only 
when most of the binding site is single-stranded. Once established, the complexes between 
long PPR tracts (e.g. those in HCF152 and PPR10) and their cognate RNAs are generally 
long-lived, and this likely underlies their effectiveness as barriers to exoribonucleases.  The 
fact that weak secondary structures at the ends of the PPR10 binding site increase PPR10’s 
off-rate suggests that breathing of the RNA-PPR complex provides opportunity for the 
competing RNA structure to form, which then inhibits reestablishment of protein-RNA 
contacts. It is notable in this context that several PPR proteins have been shown to occupy 
RNA sites in vivo that are predicted to contribute to RNA hairpins that are substantially more 
stable than those analyzed here [9, 11, 23]. Thus, it seems likely that RNA helicases and 
RNA chaperones facilitate PPR action in vivo by reducing secondary structures that would 
otherwise occlude their binding sites. Elucidating the nature of this interplay will be 
important for the design if synthetic PPR proteins and cognate binding sites, and offers an 
interesting area for future investigation. 
 
MATERIALS AND METHODS 
Protein expression and purification 
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PPR10 and HCF152 were expressed in E. coli as fusions with maltose binding protein 
(MBP), affinity purified on amylose resin, cleaved from the MBP moiety, and further 
purified by size exclusion chromatography as described previously [12, 17]. 
 
RNA thermal melting assays 
RNA thermal melting assays were performed as described in ref [24]. Free energies were 
inferred from the melting curves according to ref [25] using KaleidaGraph. RNAs were 
purchased from IDT.  Assays performed in reverse (from high to low temperatures) and at 
varying RNA concentrations gave similar values (S1A Fig).  
 
Gel mobility shift assays 
Gel mobility shift assays were performed as previously described [9], with minor 
modifications. In brief, synthetic RNA oligonucleotides (IDT) were 5’-end labeled with T4 
polynucleotide kinase and [γ-32P]-ATP. The binding reactions contained 5 pM RNA, 40 mM 
Tris-HCl pH 7.5, 140 mM NaCl, 10% glycerol, 4 mM DTT, 10 U RNAsin, 0.1 mg/mL BSA, 
0.5 mg/mL heparin, and protein at the indicated concentrations. Unless otherwise noted, 
binding reactions were incubated for 30 minutes at 25°C.  Results were imaged with a Storm 
phosphorimager and quantified with Image Studio Lite. Curves were fit to the data using a 
nonlinear regression curve fit using Prism software. The sequences of the atpH-related 
RNAs are shown in Fig 1A. The petB RNA used in HCF152 binding assays had the 





Surface Plasmon Resonance 
Biotinylated RNAs with a standard 6-carbon linker were purchased from IDT, with the 
following sequences: atpH: 5’-GAUUGUAUCCUUAACCAUUUCUUUU-3’ biotin; 
 3’-6bp: biotin 5’-AUUGUAUCCUUAACCAUUUCUUUUUUUUUGAAAGA-3’ 
 5’-6bp: 5’-ACAAUGUUUUUUAUUGUAUCCUUAACCAUUUCUUU-3’-biotin; 
 petB: 5’-UGGUAGUUCGACGUGGAUUUU-3’-biotin. 
SPR streptavidin chips (GE Sensor Chip SA) were labeled with 5 response units (RUs) 
of biotinylated RNA by injecting RNA (1 pM) in HBS buffer (100 mM HEPES pH 7.5, 150 
mM NaCl, 3 mM EDTA, 1 mM ß-mercaptoethanol, 0.005% P20 surfactant) at a rate of 10 
µL/s for 10 seconds.  This yielded a maximum of approximately 25 Response Units (RUs) 
upon protein injection, the value suggested by Katsamba et al for analysis of high affinity 
interactions [26]. We used low RNA density on the chip in order to eliminate mass transport 
effects and ligand rebinding events during the dissociation phase [27, 28]. Prior to each 
experiment, the instrument was purged three times with fresh HBS buffer and equilibrated 
for several minutes to establish a flat baseline. For analyses of PPR10 interactions with 
RNAs harboring secondary structures, lane 1 was left blank for background subtraction, lane 
2 was labeled with the atpH RNA, lane 3 was labeled with 5’-6bp RNA, and lane 4 was 
labeled with 3’-6bp RNA. Lanes 1-4 were analyzed in series with the same injections of 
PPR10 and the resulting data were statistically analyzed using a ratio paired t-test.  For 
experiments that examined the effect of salt concentration on PPR10 binding kinetics, lane 1 
was left blank for background subtraction and lane 2 was labeled with the atpH RNA; these 
data were statistically analyzed using a students t-test. For analyses of HCF152 with petB, lane 
1 was left blank for background subtraction, lane 2 was labeled with atpH RNA and lane 4 
was labeled with petB RNA; these data were statistically analyzed using a students t-test. The 
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range of protein concentrations in each experiment were injected in a random order with 
buffer injections every third injection to be used as a second background subtraction. Bound 
proteins were washed off the chip between protein injections using 0.02% SDS in HBS 
buffer. Data were analyzed using the Biacore Evaluation software. 
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BRIDGE TO CHAPTER III 
 The use of designer PPR proteins for practical purposes has yet to be shown. In the 
following chapter I describe how I developed designer PPR proteins into a tool for basic 
research – purification of a specific RNA in order to identify its bound proteins. These 
experiments also demonstrated, for the first time, that designer PPR proteins can bind the 








RIBONUCLEOPROTEIN CAPTURE VIA IN VIVO EXPRESSION OF A 
DESIGNER RNA BINDING PROTEIN 
 
This chapter contains unpublished co-authored material. J.J. McDermott, K. Watkins, 




The panoply of proteins that bind an RNA determine many aspects of its function and 
metabolism. Although excellent approaches are available for identifying RNAs bound to a 
protein-of-interest, the identification of the proteins bound to particular RNAs remains 
problematic 1. We took advantage of the programmable RNA sequence specificity of 
pentatricopeptide repeat (PPR) proteins to create a customized affinity tag for 
ribonucleoprotein purification. In a proof-of-concept experiment, we designed PPR proteins 
to bind the 3’-untranslated region of the chloroplast psbA mRNA. RIP-seq analysis of 
transgenic Arabidopsis expressing these proteins showed that they associate specifically with 
psbA RNA in vivo. Analysis of the coimmunoprecipitated proteins by mass spectrometry 
identified previously-unstudied proteins that we show are bound primarily to psbA RNA in 
vivo. Our results demonstrate that PPR proteins can be tailored to bind a specified RNA in 
vivo, and that they can be used as affinity tags to capture specific ribonucleoproteins. 
 
RESULTS AND DISCUSSION 
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PPR proteins are helical repeat proteins that influence RNA stability, processing, and 
translation in mitochondria and chloroplasts 2. PPR tracts recognize specific RNA sequences 
via a modular binding mode that is reminiscent of that between Pumilio/Fem3 (PUF) 
domains and their RNA ligands 3, such that each PPR motif binds a single nucleotide with a 
specificity that is strongly influenced by the identities of amino acids at two positions. This 
amino acid code enables the reprogramming of native PPR proteins to bind novel sequences 
4, 5, and the creation of artificial PPR proteins from consensus repeats with predictable 
sequence specificities 6-8. The ability to customize the length and sequence specificity of PPR 
tracts offers promise for applications that require the targeting of a protein to native RNA 
sequences in vivo 3, 9. A comprehensive bind-n-seq analysis confirmed that “designer” PPR 
proteins built from consensus PPR motifs (dPPRs) can be highly selective for their intended 
RNA targets in vitro 8, but the degree to which dPPR proteins bind selectively to RNAs in vivo 
has not been reported.  
In this study, we show that two dPPR proteins bind specifically to their intended 
RNA target in vivo, and we demonstrate the utility of dPPRs for a particular application – the 
purification of specific endogenous ribonucleoprotein particles (RNPs) for identification of 
the associated proteins. We chose the chloroplast psbA mRNA as the target for this proof-
of-concept experiment because it exhibits dynamic changes in translation in response to 
light, and it has been studied intensively in that context 10. We designed dPPR proteins with 
either 11 or 14 PPR motifs to bind the 3’-untranslated region (UTR) of the psbA RNA in 
Arabidopsis thaliana (Arabidopsis) (Fig. 11, Supplementary Fig. 3a). We refer to these 
proteins as SCD11 and SCD14, respectively. Because PPR proteins bind single-stranded 
RNA, we targeted the proteins to a sequence in the psbA 3’UTR that is predicted to be 
unstructured. To avoid disrupting psbA expression, we chose a target sequence that is poorly 
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conserved and that begins sufficiently far from the stop codon that the terminating ribosome 
and dPPR should not occupy the same nucleotides. We designed the proteins according to 
the scheme described by Shen and coworkers 6, such that a tract of consensus PPR motifs 
with the appropriate specificity-determining amino acids is embedded within N- and C-
terminal segments of the native chloroplast-localized protein PPR10 11. We previously 
reported a comprehensive analysis of the sequence specificity of SCD11 and SCD14 in vitro 8, 
which confirmed them to be highly selective for their intended target sequence. For the in 
vivo assays described here, the proteins include, in addition, a C-terminal FLAG tag and the 
N-terminal chloroplast targeting sequence from PPR10, which is cleaved after chloroplast 









Immunoblot analysis of leaf and chloroplast fractions from transgenic Arabidopsis 
plants expressing SCD11 and SCD14 confirmed that they localize to chloroplasts (Fig. 12). 
Figure 11.  dPPR design. SCD14 and SCD11 were designed to bind the indicated 14 
or 11 (underlined) nucleotide sequence, respectively, in the 3’-UTR of the psbA 
mRNA in Arabidopsis. The targeted sequence begins 13 nucleotides downstream of 
the stop codon, and ends five (SCD14) or eight (SCD11) nucleotides upstream of the 
3’-terminal stem-loop in the psbA mRNA. SCD14 and SCD11 contain 13 and 10 
consensus PPR motifs, respectively, flanked by sequences from PPR10 (green). The 
motifs that are found in SCD14 but not in SCD11 are marked in gray. The specificity-
determining amino acids (positions 5 and 35 in each motif) are indicated, and each 
repeat is aligned with its nucleotide ligand. The PPR10-derived sequence at the N-
terminus includes a chloroplast targeting sequence and PPR10’s first PPR motif, 
which has a non-canonical specificity code (dotted line). The targeting sequence is 
cleaved after import into the chloroplast (scissors). Both proteins contain a C-terminal 
3x FLAG tag. 
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Both proteins were found predominantly in the soluble fraction, which is as expected given 
that they lack transmembrane segments or thylakoid targeting signals. Laddering beneath the 
band corresponding to each full-length protein suggests that these artificial proteins are 
prone to proteolysis in vivo. The transgenic plants were phenotypically normal 
(Supplementary Fig. 3) and had normal levels of PsbA protein (Fig. 12) indicating that the 






To identify the RNAs to which SCD11 and SCD14 are bound in vivo, we isolated 
chloroplasts from the transgenic plants and immunoprecipitated each protein from stromal 
extract by using anti-FLAG antibody (Supplementary Fig. 4a). Slot-blot hybridization 
analysis of RNA from these immunoprecipitates showed that psbA RNA was highly enriched 
from extracts of the transgenic lines in comparison to the wild-type progenitor (Col-0) 
(Supplementary Fig. 4b). Furthermore, RNA from the 3’UTR was more highly enriched 
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Figure 12.  dPPR chloroplast 
localization. Immunoblots demonstrating 
chloroplast-localization of SCD11 and 
SCD14. Chloroplasts (Cp) were isolated 
from total leaf extract (T) of wild-type 
(Col-0) and transgenic Arabidopsis plants, 
and fractionated to generate thylakoid 
membrane (Th) and soluble (S) fractions. 
Aliquots representing an equivalent 
amount of starting material were probed 
to detect markers for cytosol (actin), 
mitochondria (CoxII), and thylakoid 
membranes (PsbA). The dPPR proteins 
were detected with anti-FLAG antibody. 
The Ponceau S-stained filter is shown 
below to demonstrate the partitioning of 
the chloroplast stromal protein RbcL 
among the fractions.  
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sequence in the psbA 3’-UTR. To gain a comprehensive view of the RNAs bound to each 
protein, we sequenced the coimmunoprecipitating RNA (RIP-seq) (Fig. 13). Comparison of 
these RNAs to those in a pellet from an immunoprecipitation with an antibody that does not 
recognize proteins in Arabidopsis showed that the psbA RNA strongly and specifically 
coprecipitated with SCD11 and SCD14 (Fig. 13, right and bottom). To our knowledge, this 
is the first reported evidence that dPPR proteins can bind specifically to intended RNA 








 We next used mass spectrometry to identify proteins that coimmunoprecipitate with 
SCD11 and SCD14 from chloroplast stroma. Approximately 400 different proteins were 
identified in at least one of the immunoprecipitates. The enrichment of each protein was 
b






SWIB-2, DNA binding 12
PSAE-2, PSI AT2G20260 10
Ribosomal protein-like AT1G16790 8
PSB27, PSII AT1G03600 8
RPL32, ribosome AT1G01020 7
HCF173, psbA translation AT1G16720 6
RPL35, ribosome AT2G24090 5
AT2G36835Unknown 5
YebC-like, translation factor AT2G25830 5
Glycine-rich protein AT1G66820 4
Peroxiredoxin Q, redox homeostasis AT3G26060 5
PSBQ, PSII AT4G21280 4
P-loop NTPase, putative DNA binding AT5G35970 4
RNA binding protein (RRM domain) AT4G09040 4
Translation initiation factor 3 AT2G24060 4
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IgGSWIB-2, DNA binding AT4G34290 38 0 8
Figure 13. Analysis of RNAs that coimmunoprecipitate with SCD11 and SCD14. 
RIP-seq analysis of RNAs that coimmunoprecipitate with SCD11 and SCD14. Anti-
FLAG anti odies were used for immunoprecipitation from extracts of chloroplasts from 
transgenic plants expressing SCD11 or SCD14. The negative control used chloroplast 
extract fro  the Col-0 progenitor and an antibody that does not detect proteins in that 
extract. Results at top are plotted as the average sequence coverage in consecutive 10-nt 
windows long the chloroplast genome (Accession NC_0 0932.1), per million reads 
mapped to the chloroplast genome. An alternative view of the data showing the ratio of 




calculated with respect to its representation in an anti-FLAG immunoprecipitate from the 
non-transgenic host line (Col-0). Proteins with an average enrichment of at least 3-fold are 
listed in Fig. 14a. This protein set included several proteins that are known to associate with 
psbA mRNA: HCF173, which activates psbA translation 12, cpSRP54, which binds 
cotranslationally to PsbA 13, and various ribosomal proteins and translation factors. 
Immunoblot analysis of anti-FLAG coimmunoprecipitates confirmed that HCF173 and 
cpSRP54 coimmunoprecipitate with the dPPR proteins from extracts of the transgenic 
plants (Fig. 14b). The differing efficiency with which these proteins were coprecipitated 
from the two lines may be due to differing degrees of RNA degradation in the two 
preparations, as RNA cleavage upstream from the 3’UTR will separate the bound dPPRs 
from proteins bound elsewhere on the RNA. 
Two uncharacterized proteins with predicted RNA binding domains were enriched in 
the dPPR coimmunoprecipitates: AT3G23700, which has two S1 RNA binding domains, 
and AT4G09040, which has two RRM RNA binding domains (Fig. 14a, stars; sequences 
shown in Supplementary Fig. 5a). We generated antibodies to the maize orthologs of these 
proteins and confirmed their specificity by immunoblot analysis of corresponding loss-of-
function mutants (Supplementary Fig. 5b). The antibodies were then used for RIP-seq 
analysis with maize chloroplast extract; we could not use Arabidopsis extract due to lack of 
antibody cross-reactivity. The psbA RNA was highly enriched in each coimmunoprecipitate, 
in comparison to its representation in the input RNA (Fig. 13). Several other RNA ligands 
were also identified in each case (Fig. 14a). These results validate the utility of the dPPR-
affinity tag approach to identify proteins that associate with a specific RNA-of-interest in 
vivo. It will be interesting to explore the roles of these proteins in the expression of their 









Several methods for the RNA-centric purification of RNPs have been reported 
previously. Some of these rely on the insertion of an RNA affinity tag into the target RNA  
14, 15, 16. However, insertions can alter RNA functionalities, modification of endogenous genes 
is technically challenging in some experimental systems (such as organelles), and expression 
of ectopic modified genes can disrupt the balance of trans-factors to their cis-targets. These 
limitations are addressed by assays that purify untagged RNPs by coupling in vivo crosslinking 
with post-lysis antisense oligonucleotide purification  17, 18, 19. However, UV crosslinking is 
inefficient and is practical only with cultured cells or lysates. Formaldehyde crosslinking 
provides an alternative, but is prone to capturing both transient and stable interactions. Very 
recently, a Type VI-related CRISPR-Cas system was engineered to bind and modify the 
b
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IgGSWIB-2, DNA binding AT4G34290 38 0 8
Figure 14. Analysis of proteins that coimmunoprecipitate with SCD11 and SCD14. 
(a) Highly-enriched proteins in SCD11 and SCD14 coimmunoprecipitates, as detected 
by LC-MS/MS. The table lists proteins whose average enrichment from lines expressing 
SCD11 or SCD14 in comparison to the Col-0 progenitor was three or greater. Stars 
mark two uncharacterized RNA binding proteins. HCF173 is known to bind psbA RNA 
12.  (b) Immunoblot validation of several proteins identified by MS/MS analysis. 
Chloroplast stroma from plants expressing SCD11 or SCD14, or from the Col-0 
progenitor was used for immunoprecipitation with anti-FLAG antibody. Replicate 
immunoblots were probed to detect SCD11 or SCD14 (anti-FLAG), HCF173, or 
cpSRP54. The HCF173 blot was initially probed to detect RbcL, an abundant protein 
that typically contaminates immunoprecipitates, which serves as an internal standard.  
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splicing of endogenous RNAs 20. Whether this system can achieve the degree of RNA 








Designer PPR affinity tags add to this toolkit by binding unmodified RNPs within intact 
tissues, and allowing their purification under non-denaturing conditions.  Given the 
successes in using designer PUF proteins to modify the expression of specific mRNAs 21, 22 
and to track untagged RNAs in vivo 23, they may also be useful as affinity tags for the 
purification of specific RNPs. However, the greater flexibility in repeat tract length with the 
PPR scaffold 3 may facilitate customization of RNA binding affinity, kinetics, and specificity 
for this application. A caveat relevant to the general applicability of our approach is that PPR 

































































































































































































































Figure 15. RIP-Seq analysis demonstrating identification of previously-unknown 
psbA-specific RNA binding proteins in the dPPR-affinity purifications. Maize 
chloroplast stroma was used for immunoprecipitations with antibodies to the maize 
orthologs of the RRM and S1-domain proteins that were enriched in dPPR-
coimmunoprecipitations (AT4G09040 and AT3G23700, respectively). Results at top are 
plotted as the average sequence coverage in consecutive 10-nt windows along the 
chloroplast genome, per million reads mapped to the chloroplast genome (NCBI 
NC_001666). An alternative view of the data showing the ratio of normalized reads/gene 




as yet unclear how they will perform in the nuclear-cytosolic compartment. Thus, an 
important next step is to test this approach on a cytosolic target RNA. 
 
METHODS 
Development of transgenic lines 
Genes for SCD14 and SCD11 were codon-optimized for Arabidopsis and assembled by 
PCR from several overlapping synthetic DNA fragments (IDT). The protein sequences are 
provided in Supplemental Fig. 3a. They were designed with the PPR nucleotide specificity 
codes described previously 4, 8 and summarized in Fig. 11. The PPR-encoding genes were 
inserted into a modified form of pCambia1300 24 that encodes a 3X-FLAG tag at the C-
terminus of the inserted ORF (a gift from Jie Shen and Zhizhong Gong, China Agricultural 
University). The plasmids were used to transform Arabidopsis thaliana (ecotype Col-0) 
(Arabidopsis) using the floral dip method 25. Lines were screened by immunoblotting for 
dPPR expression, and those with the highest expression were used for further experiments. 
An additional transgenic line was developed using the MCD14 protein design we reported 
previously 8; however, MCD14 transgenic lines failed to express the protein.  
 
Plant growth 
Arabidopsis seeds were sterilized by incubation for 10 min in a solution containing 1% 
bleach and 0.1% SDS, followed by a 70% ethanol wash.  The seeds were then washed three 
times with sterile water. Seeds were plated and grown in tissue culture dishes containing MS 
agar medium: 4.33 g/L Murashige and Skoog basal salt medium (Sigma), 2% sucrose, 0.3% 
Phytagel, pH 5.7. Transgenic plants were selected by the addition of 50 µg/mL hygromycin 
to the growth medium. Plants used for chloroplast isolation and immunoprecipitation assays 
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were grown in a growth chamber in diurnal cycles (10 h light at 120 µE light intensity, 14 h 
dark, 22˚C) for 14 days.  
 
Chloroplast isolation and fractionation 
Maize chloroplast stroma for use in RIP-seq assays was prepared as described previously 
26. Arabidopsis chloroplast stroma was prepared from chloroplasts isolated from the aerial 
portion of 2-week old seedlings (40 g tissue) as described 27, with the following 
modifications: seedlings were not placed in ice water before homogenization, sorbitol 
concentration in the homogenization buffer was reduced to 0.33 M, and plants were 
homogenized in a blender using three 5-second bursts. Purified chloroplasts were 
resuspended and lysed in Hypotonic Lysis Buffer (30 mM HEPES-KOH pH 8.0, 10 mM 
MgOAc-4H2O, 60 mM KOAc, 2 mM DTT, 2 µg/mL aprotinin, 2 µg/mL leupeptin, 1 
µg/mL pepstatin A, 0.8 mM PMSF), using a minimal buffer volume so as to maximize 
protein concentration in the extract. Lysed chloroplasts were centrifuged for 40 min at 
18,000 x g at 4˚C in a tabletop microcentrifuge to pellet membranes and particulates. The 
supernatant was removed, and the pellet was resuspended in Hypotonic Lysis Buffer and 
centrifuged again under the same conditions. Supernatants were combined, aliquoted, and 
frozen at -80 °C. The thylakoid membranes (pellet fraction) were aliquoted and frozen at -80 
°C. 
 
Antibodies, SDS-Page, and immunoblot analysis 
SDS-PAGE and immunoblot analyses were performed as described previously 28. A 
mouse monoclonal anti-FLAG M2 antibody was purchased from Sigma. Polyclonal 
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antibodies were raised in rabbits to recombinant fragments of the maize orthologs of 
HCF173, AT4G09040 and AT3G23700 (the uncharacterized RRM and S1-domain proteins, 
respectively, that coimmunoprecipitated with the dPPRs); these correspond to maize genes 
GRMZM2G397247, GRMZM2G023591, and GRMZM2G016084, respectively (see 
http://cas-pogs.uoregon.edu/#/ for evidence of orthology). The amino acids used for the 
S1 and RRM protein antigens and evidence for the specificity of the resulting antisera are 
shown in Supplementary Fig. 3. Amino acids 364-633 were used for Zm-HCF173.  The 
maize CRP1 antibody was described previously 29. Antibodies were affinity purified against 
their antigen prior to use.  
 
Coimmunoprecipitation experiments 
Immunoprecipitation for analysis of proteins by mass spectrometry was performed as 
described previously 30 with minor modifications. In brief, experiments used Arabidopsis 
stromal extract, anti-FLAG antibodies were crosslinked to magnetic Protein A/G beads 
(Pierce), the beads were pre-washed in CoIP Buffer (20 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 0.5% NP-40, 5 µg/mL aprotinin), and the antibody cross-linked beads 
were titrated to determine the amount required to deplete the dPPR from the stromal 
extract. Stromal extract (400 µL at 6 mg protein/ml) was supplemented with RNAsin 
(Promega) to a concentration of 1 unit/µL and precleared by centrifugation for 10 min at 
18,000 x g at 4 ˚C. The supernatant was removed to a new tube, antibody-bound beads were 
added and the mixture was incubated at 4 °C for one hour while rotating.  Beads were 
captured with a magnet (Invitrogen) and the supernatant was removed. The beads (pellets) 
were washed three times with CoIP Buffer and then twice with 50 mM ammonium 
bicarbonate (pH 7.5). Proteins were digested on the beads with trypsin (Promega mass 
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spectrometry grade at 25 ng/µL in 50 mM ammonium bicarbonate pH 7.5) overnight at 25 
°C while shaking. Beads were captured and the supernatant was transferred to a new tube. 
This step was repeated five times to ensure the removal of all beads. LC-MS/MS was 
performed by the UC Davis Proteomics Core Facility, where the data were analyzed using 
Scaffold2 (Proteome Software Inc). Protein enrichment was calculated by dividing the 
average Normalized Spectral Abundance Factor (NSAF) values 31 from the two dPPR lines 
by NSAF values from the control immunoprecipitation using extract of Col-0 plants. To 
avoid division by zero, a correction term of 0.001 was added to each NSAF value in the 
control; therefore, the actual enrichment of proteins that were not detected in the control is 
under-estimated.  
Immunoprecipitations for RIP-seq analysis were performed similarly, except that 
antibodies were not crosslinked to the beads, the Arabidopsis experiments used 200 µl of 
extract, and the maize experiments used 70 µl of stromal extract at ~10 mg protein/ml and 
did not include RNAsin.  Antibody to maize CRP1 was used as a negative control for the 
dPPR RIP-seq assays; this antibody does not recognize proteins in Arabidopsis chloroplasts. 
 
Analysis of immunoprecipitation RNA by RIP-seq and slot blot analysis 
An equal volume of TESS Buffer (10 mM Tris pH 7.5, 1 mM EDTA, 150 mM NaCl, 
0.2% SDS) supplemented with Proteinase K (0.2 µg/µL) was added to the supernatant and 
pellet fractions and incubated for 30 min at 37 °C. RNA was then purified by phenol-
chloroform extraction and ethanol precipitation, resuspended in H2O, and quantified by 
Qubit.  The RNA was used directly for slot-blot hybridizations as previously described 32, or 
processed for sequencing using the BIOO Scientific NEXTflex Small RNA-Seq Kit v3 
(Cat# NOVA-5132-06).  For Arabidopsis, 50 ng of pellet RNA was used as the input for 
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sequencing libraries. The maize experiments used 20 ng of pellet or input RNA for library 
preparation, and included an RNA fragmentation step: RNA was fragmented by incubation 
at 95 ˚C for 4 min in 40 mM Tris-Acetate pH 8, 100 mM KOc, 30 mM MgOAc2. The 
reaction was stopped by the addition of EDTA to a final concentration of 50 mM, and the 
RNA was ethanol precipitated in the presence of 1.5 µg GlycoBlue (Thermo Fisher). 
Libraries were gel purified to enrich for inserts between 15 and 100 nucleotides. Libraries 
were sequenced at the University of Oregon Genomics and Cell Characterization Core 
Facility, with read lengths of 75 or 100 nucleotides. Sequencing data were processed as in 33 
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BRIDGE TO CHAPTER IV 
 In this chapter, I described the target specificity of designer PPR proteins in vivo and their 
utility as an in vivo biotechnological tool. The results showed that dPPR proteins bind to their 
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targets in vivo and can be used as an “affinity-tag” to purify endogenous transcripts and 
identify bound RNPs. In the following chapter I summarize the findings of this dissertation 
and describe the implications and possible future directions for the findings, with a specific 























SUMMARY AND FUTURE CONSIDERATIONS 
 
SUMMARY 
PPR proteins function in organellar RNA metabolism and are critical for the 
development of all eukaryotes. In the first chapter of this dissertation I introduce PPR 
proteins and the cellular compartments where they function – the DNA containing 
organelles – with a focus on the PPR proteins found in plants. I discuss the in vivo functions 
and the binding mechanisms of PPR proteins, and I discuss knowledge gaps in the literature 
of PPR proteins that I answer in the proceeding chapters.  
In the second chapter of this dissertation I focused on developing a deeper 
understanding of the mechanisms of PPR:RNA interactions, specifically what parameters 
influence binding affinity and kinetics. PPR proteins are crucial for the proper expression of 
genes in organelles and yet we don’t fully understand how the dynamic nature of RNA 
structure impacts PPR:RNA binding and function. I demonstrate how the stability and 
position of RNA secondary structure inhibits PPR10:atpH interactions and show that even 
weak RNA structures inhibit PPR10:atpH binding. Additionally, I show how RNA secondary 
structure affects the binding kinetics of PPR10:atpH interactions. RNA secondary structure 
slowed down the PPR10:atpH on-rate – which was an expected outcome based on the fact 
that the secondary structure would sterically inhibit PPR10 from interacting with the 
Watson-Crick face of its binding site nucleotides. A more perplexing result was the fact that 
RNA secondary structure increased the off-rate of PPR10:atpH interactions. We 
hypothesized that the PPR10:atpH complex can “breathe”, similar to DNA duplex 
breathing, and during this breathing, the RNA structure can reform which causes the protein 
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to prematurely dissociate thus increasing the off-rate. I also demonstrated how electrostatic 
forces influence the binding kinetics, and how there is not a simple relationship between 
PPR protein length and the binding kinetics when comparing two native PPR proteins.   
The customizable binding specificity of PPR proteins makes them attractive for a variety 
of applications. In Chapter III of this dissertation I demonstrate the feasibility of using 
synthetic PPR proteins as tools for basic science research in vivo. I showed that synthetic 
PPR proteins can be engineered to bind to a specific chloroplast transcript in vivo and can be 
used to co-purify the transcript and bound ribonucleoproteins (RNPs). These designer PPR 
proteins bound quite specifically to their intended RNA target (chloroplast psbA RNA), but 
this finding is likely influenced by the fact that chloroplasts have a limited sequence space 
(~110,000 bp). Nonetheless, this was the first demonstration, to my knowledge, that a 
designer PPR protein behaves predictably in vivo. In addition, this provides a new tool for the 
purification of endogenous RNPs for proteomic analysis. Our success using it for this 
purpose was likely enhanced by the fact that psbA mRNA is the most abundant mRNA in a 
plant cell.  I highlight other potential designer uses of synthetic PPR proteins in the 
subsequent sections. 
 
Implications of the effects of RNA structure on the binding affinity and kinetics of 
PPR proteins 
Results presented in Chapter II revealed that RNA structure stability and position impact 
PPR:RNA interactions, and that even weak RNA structures of DG° ~ 0 kcal/mol inhibit 
PPR:RNA interactions. It is likely that many PPR protein binding sites could form RNA 
structures in vivo thus it is unclear how PPR proteins are able to bind to these sequestered 
binding sites. It is likely they are assisted by RNA helicases or chaperones, so a paramount 
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next step would be to examine the impact of these proteins on PPR binding in vivo. The 
influence of RNA secondary structure on PPR binding will impact the design of future 
synthetic PPR proteins and will be an important factor to consider. I also showed how 
electrostatic forces influence the binding kinetics, specifically the on-rate of PPR10:atpH 
interactions. With two native PPR proteins, I demonstrated that there is not a simple 
relationship between the length of the PPR protein and the binding kinetics. Because native 
proteins like the ones I examined are known to have idiosyncratic features, it would be 
interesting to do analogous experiments with artificial proteins built from consensus PPR 
motifs in the future. Investigations in this area would also be fruitful in the design of 
synthetic PPR proteins. Understanding the structure-function relationship of PPR proteins 
and their binding kinetics and affinity could lead to the development of designer PPR 
proteins with customized binding kinetics and affinities for specialized purposes that I 
highlight in the section below.   
 
Implications and the future applications of designer PPR proteins  
Chapter III of this dissertation developed the use of synthetic PPR proteins for designer 
purposes. I successfully showed that designer PPR proteins bind specifically to their target 
sequences in vivo and can be used as a tool to purify an endogenous transcript and identify 
proteins bound to that transcript.  
The use of engineered PPR proteins as a biotechnology has been almost 25 years in the 
making. This journey began as an observation concerning the basic science of RNA 
metabolism in chloroplasts in 1994 [Barkan et al. 1994] and has come full circle to the 
development of engineered PPR proteins for biotechnology applications in 2018.  
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I have demonstrated one potential future use of PPR proteins as a biotechnology. There 
are many other potential uses of PPR proteins that have yet to be realized [Yagi et al. 2013]. 
Many of these future applications could stem from the functions of native PPR proteins. 
Native PPR proteins function by i.) sequestering long segments of RNA which prevents the 
RNA from interacting with other proteins or RNA or exposes a cis-element masked in an 
RNA hairpin that is then free to interact with other proteins or RNA, or ii.) the action of an 
accessory domain attached to the PPR protein [reviewed in Barkan and Small 2014]. By the 
first mechanism, designer PPR proteins could be used as sequence specific binders to block 
cis elements (such as RNA splice sites, or protein binding sites) from interacting with RNA 
or proteins and affect downstream RNA actions; this could have applications in basic 
research and biotechnology – similar to how small RNA oligonucleotides are used as tools 
for synthetic RNA biology [Reviewed in Isaacs et al. 2006 and Sazani and Kole 2003]. 
Through the second mechanism, an accessory domain could be attached to the designer 
PPR protein to provide a secondary action after the PPR motifs have guided the protein to 
the site of interest. These accessory domains could be i.) nucleases or RNA editing domains 
which would disrupt or change the fate of the RNA transcript, ii.) fluorescent domains, such 
as GFP, which could be used to track the localization of a transcript of interest [Bertrand 
1998], iii.) a localization factor which could localize the RNA to specific cellular 
compartments, or iv.) as I showed in Chapter III of this dissertation, the designer PPR 
protein could be linked with an epitope like a FLAG tag which could be used to purify the 
PPR protein, target transcripts, and RNPs for the identification of RNA binding proteins 
associating with a particular transcript. Other methods are capable of purifying endogenous  
transcripts and RNPs, but many require a change in the RNA sequence [Panchapakesan et 
al. 2017, Butter et al. 2009, Ramanathan et al 2018]. Genetic engineering can be difficult in 
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organelles and can also create unexpected complications for the RNA. Other methods use 
oligonucleotides to recognize and purify the transcript, but these procedures have yet to be 
adopted into organelles [Rogell et al. 2017, McHugh et al. 2015, Chu et al. 2015]. PPR 
proteins offer the advantage of using a protein-based system which can easily be 
transformed or transfected into the nuclear genomes of model organisms and customized to 
bind to an existing RNA sequence. They are also easily targeted to organelles as I 
demonstrated in Chapter III.  
Other customizable RNA binding proteins, such as CRISPR-CAS or engineered PUF 
proteins, could be used in these same applications [Nelles et al. 2016, Konermann et al 2018, 
Campbell et al. 2014], however the diversity of PPR motifs (P, L, and S motifs) provides a 
more malleable template for which to customize the binding affinity and kinetics to achieve 
the variety of designer functions mentioned above – a parameter that these other systems 
may be unable to achieve. PPR proteins also offer an advantage in organelles, where PUF 
and CRISPR-CAS proteins have yet to be successfully targeted. Additionally, CRISPR-CAS 
systems require a guide RNA and currently it is technically impossible to introduce guide 
RNAs into mitochondria and chloroplasts.  
The binding kinetics and affinity will likely impact the efficiency of the designed function 
of the synthetic PPR. Synthetic PPR proteins with an additional nuclease or editing domain 
will function best with fast on-rates and off-rates. Ideally, these proteins would quickly find 
their targets, perform their functions, and then dissociate to interact with a new transcript. 
On the other hand, synthetic proteins designed to activate translation, block a cis-element, or 
be used as an “affinity tag” would function optimally with fast on-rates and slow off-rates. 
Similarly, these proteins would quickly find their targets, but would seldom dissociate – an 
ideal function for their purpose.  
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One of the key challenges for the future development of designer PPR proteins is to 
determine if they will function outside the context of an organelle. Very few PPR proteins 
are predicted to localize to the cytosol [Hammani et al 2016], and so many potential 
applications will hinge on the ability of synthetic PPR proteins to function in the cytosol. It 
will be necessary to perform future experiments and optimizations in this area. 
 
CLOSING REMARKS 
In this dissertation I have made significant contributions towards understanding the 
mechanisms of PPR:RNA interactions, specifically how they interact with RNA secondary 
structure, a parameter that will likely impact the in vivo function of PPR proteins. 
Additionally, the modular nature of PPR proteins make them excellent targets for the design 
of bespoke proteins. This dissertation investigated one potential avenue for designer PPR 
proteins and shows their viability as a method to purify endogenous transcripts and 
associated RNPs. Given these results and the malleable, modular, and programmable nature 
of PPR proteins there is a bright future for designer PPR proteins in translational control, 
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S1 Fig. (A) Predicted and measured stabilities of the atpH-related RNAs diagrammed in Fig 1A. (B) Representative gel mobility 
shift assays underlying the curves presented in Fig 2. See Fig 2 for details.
S1 Fig.  (A) Predicted and measured stabilities of the atpH-related RNAs diagrammed 
in Fig 1A. (B) Representative gel mobility shift assays underlying the curves presented 





































































S2 Fig. (A) Specificity controls for PPR10 and HCF152 SPR assays. Sensorgrams are shown for the analysis of PPR10 interaction with 
HCF152’s petB RNA ligand (left) and HCF152’s interaction with PPR10’s atpH RNA ligand (right). (B) SPR analysis of PPR10 interaction 
with the 3’-6bp RNA ligand (see Fig 1A). The experiment was performed as in Fig 3A except that the RNA was tethered to the SPR chip 
via biotin at its 5’-end. PPR10 was used at a concentration of 5 nM and 2-fold dilutions thereof. (C) Residuals for SPR assays. (D) 
Examples of gel mobility shift and filter binding data supporting the curves shown in Fig 3C. (E) Gel mobility shift assay of PPR10-atpH 23 
mer interactions, using the same PPR10 protein preparation as used in the SPR assays. PPR10 was used at a concentration of 2.5 nM 
and 2-fold dilutions thereof. 
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S2 Fig (A) Specificity controls for PPR10 and HCF152 SPR assays. Sensorgrams are 
shown for the analysis of PPR10 interaction with HCF152’s petB R A ligand (left) and 
HCF152’s interactio  with PPR10’s atpH RNA ligand (r ht). (B) SPR analy is of PPR10
interaction with the 3’-6bp RNA ligand (see Fig 1A). The experiment was performed as 
in Fig 3A except that the RNA was tethered to the SPR chip via biotin at its 5’-end. 
PPR10 was used at a concentration of 5 nM and 2-fold dilutions thereof. (C) Residuals 
for SPR assays. (D) Examples of gel mobility shift and filter binding data supporting the 
curves shown in Fig 3C. (E) Gel mobility shift assay of PPR10-atpH 23 mer interactions, 
using the same PPR10 protein preparation as used in the SPR assays. PPR10 was used at 









































Supplementary Figure 1. Sequences of SCD14 and SCD11 and their lack of effect 
on plant phenotype.Supplementary Figure 3. Sequences of SCD14 and SCD11 and their lack of 
effect on plant phenotype. (a) Amino acid sequences of SCD14 and SCD11. Amino 
acids derived from PPR10 are in green. The C-terminal FLAG tag is on bold black 
font. (b) Visible phenotype of transgenic Arabidopsis plants expressing SCD14 and 
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Supplementary Figure 4. Controls for coimmunoprecipitation experiments.  (a) 
Immunoprecipitation of SCD14 and SCD11 from transgenic lines. Stromal extracts 
isolated from transgenic Arabidopsis expressing the indicated protein or from the Col-0 
progenitor were used for immunoprecipitation with anti-FLAG antibody. The pellet (P) 
and supernatant (S) fractions were analyzed by immunoblot analysis, using anti-FLAG 
antibody. An excerpt of the Ponceau S-stained filter is shown to illustrate the abundance 
of the large subunit of Rubisco (RbcL), which serves as a loading control. An equal 
proportion of each pellet fraction was analyzed; 1/4th that proportion of each 
supernatant was analyzed to avoid overloading the lane. (b) Slot blot hybridization 
analysis of RNAs that coimmunoprecipitate with SCD14 and SCD11 from chloroplast 
stroma. RNA was extracted from the same immunoprecipitations analyzed in panel (a) 
and applied to nylon membrane via a slot-blot manifold.  The same proportion of all 
RNA samples was analyzed to illustrate the partitioning of psbA RNA between the pellet 
and supernatant fractions. Replicate blots were hybridized with synthetic oligonucleotide 


































































 GGATATCTTCGCCATCCG Mu CGCCATCCGTTGCCTCGC
(-30)
ATG (+1)






Supplementary Figure 3. Validation of antibodies used for RIP-seq assays.
Supplementary Figure 5. Validation of antibodies used for RIP-seq assays. 
(a) Multiple sequence alignments of the maize and Arabidopsis orthologs of the RRM-domain 
and S1-domain proteins enriched in the SCD11/14 coimmunoprecipitations. The RRM protein 
is encoded by gene AT4G09040 and GRMZM2G023591 in Arabidopsis and maize, respectively. 
The S1 domain protein is encoded by genes AT3G23700 and GRMZM2G016084 in 
Arabidopsis and maize, respectively. Arrows mark the first amino acid of the recombinant 
proteins used to raise polyclonal antibodies. (b) Specificity of antibodies demonstrated by 
immunoblot analysis of maize insertion alleles. The transposon insertion alleles are diagrammed 
to the right, and were obtained from the UniformMu project: the GRMZM2G023591/RRM 
mutant corresponds to line (mu1032521, UFMu-02565); the GRMZM2G016084/S1 mutant 
corresponds to line (mu1076060, UFMu-09028). Total leaf extracts from wild-type or mutant 
seedlings were probed with the indicated antiserum. Excerpts of the Ponceau-stained blots are 
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